Regency Capital Management Inc.\De Imago Bio Sciences, Inc. Transaction History

Regency Capital Management Inc.\De

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$15.03 - $35.96 $150 - $359	-10 Reduced 0.06%	18,000 $0
Q3 2022 Nov 04, 2022	SELL	$14.15 - $19.5 $566 - $780	-40 Reduced 0.22%	18,010 $271,000
Q2 2022 Aug 03, 2022	BUY	$11.81 - $20.92 $213,170 - $377,606	18,050 New	18,050 $242,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Regency Capital Management Inc.\De, based on Form 13F filings with the SEC.

Stay updated on Regency Capital Management Inc.\De with notifications on news.